Evidence map›Paper›PMID 19557167›Full record

Trial reportPloS one2009

Differential effects of early weaning for HIV-free survival of children born to HIV-infected mothers by severity of maternal disease.

Louise Kuhn, Grace M Aldrovandi, Moses Sinkala, Chipepo Kankasa, Katherine Semrau, Prisca Kasonde, Mwiya Mwiya, Wei-Yann Tsai, Donald M Thea, Zambia Exclusive Breastfeeding Study (ZEBS)

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00310726 nacompletednot on this map

Short Duration Exclusive Breastfeeding With Abrupt Weaning to Reduce the Risk of Mother-to-Child HIV Transmission

TypeinterventionalSponsorBoston Medical CenterRan2001 to 2006Enrolled1,435ConditionsHIV InfectionArmsabrupt weaning at 4 months, Continued exclusive breastfeeding
NCT02459678 nacompletednot on this mapstarted 2015, after this paper: background citation

ART Readiness in HIV-infected Pregnant Women: From Formative Qualitative Research to Individual Randomized Trial

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2015 to 2018Enrolled454ConditionsHuman Immunodeficiency VirusArmsEnhanced Adherence Package, Standard of Care
3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Immunology of pediatric HIV infection.Immunological reviews · 2013
    Review
  17. Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2012
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Louise KuhnGertrude H Sergievsky Center, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. lk24@columbia.edu
Grace M Aldrovandi
Moses Sinkala
Chipepo Kankasa
Katherine Semrau
Prisca Kasonde
Mwiya Mwiya
Wei-Yann Tsai
Donald M Thea
Zambia Exclusive Breastfeeding Study (ZEBS)

Funding

Short Exclusive Breastfeeding to Reduce Postnatal Transmission of HIVR01HD039611 · NICHD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI THEA, DONALD M · 2000 to 2006
$8.0M
Pathogenesis of Mother to Child Transmission of HIVR01HD040777 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALDROVANDI, GRACE M · 2002 to 2011
$4.4M
NICHD NIH HHS R01 HD039611NICHD NIH HHS R01 HD040777NICHD NIH HHS R01 HD 39611NICHD NIH HHS R01 HD 40777
6 · The paper itself

Abstract

backgroundWe previously reported no benefit of early weaning for HIV-free survival of children born to HIV-infected mothers in intent-to-treat analyses. Since early weaning was poorly accepted, we conducted a secondary analysis to investigate whether beneficial effects may have been hidden.

methods958 HIV-infected women in Lusaka, Zambia, were randomized to abrupt weaning at 4 months (intervention) or to continued breastfeeding (control). Children were followed to 24 months with regular HIV PCR tests and examinations to determine HIV infection or death. Detailed behavioral data were collected on when all breastfeeding ended. Most participants were recruited before antiretroviral treatment (ART) became available. We compared outcomes among mother-child pairs who weaned earlier or later than intended by study design adjusting for potential confounders.

resultsOf infants alive, uninfected and still breastfeeding at 4 months in the intervention group, 16.1% who weaned as instructed acquired HIV or died by 24 months compared to 16.0% who did not comply (p = 0.98). Children of women with less severe disease during pregnancy (not eligible for ART) had worse outcomes if their mothers weaned as instructed (RH = 2.60 95% CI: 1.06-6.36) compared to those who continued breastfeeding. Conversely, children of mothers with more severe disease (eligible for ART but did not receive it) who weaned early had better outcomes (p-value interaction = 0.002). In the control group, weaning before 15 months was associated with 3.94-fold (95% CI: 1.65-9.39) increase in HIV infection or death among infants of mothers with less severe disease.

conclusionIncomplete adherence did not mask a benefit of early weaning. On the contrary, for women with less severe disease, early weaning was harmful and continued breastfeeding resulted in better outcomes. For women with more advanced disease, ART should be given during pregnancy for maternal health and to reduce transmission, including through breastfeeding.

trial registration(ClinicalTrials.gov) NCT00310726.

Indexed as

WeaningAIDS SerodiagnosisAnti-HIV AgentsDisease-Free SurvivalFemaleHIV InfectionsHumansInfectious Disease Transmission, VerticalMothersPatient CompliancePolymerase Chain ReactionPregnancyPregnancy Complications, InfectiousTreatment OutcomeZambiaAnti-HIV Agents

Identifiers

PMID19557167
PMCPMC2698120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.